Trade VCEL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Vericel Corporation (VCEL) is trading at US$41.52, up 0.83% today as of Aug 28, 09:32 EDT. The company has a market capitalisation of US$2.19B. Over the past 52 weeks, VCEL has traded between US$28.95 and US$49.32. On Syfe you can trade VCEL with $0 commission and add it to your watchlist.
| Previous close | US$41.18 |
|---|---|
| Market cap | US$2.19B |
| P/E ratio | 55.21 |
| 52-week range | US$28.95 – US$49.32 |
| Volume | 533.42K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vericel Corporation
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Year: 1997
Vericel Corporation (VCEL) stock is trading at US$41.52, +0.83% from the previous close of US$41.18.
The market cap for Vericel Corporation (VCEL) stock is approximately US$2.19B.
The price-to-earnings ratio for Vericel Corporation (VCEL) is 55.21, based on the latest reported earnings.
The 52-week high for Vericel Corporation (VCEL) stock is US$49.32.
The 52-week low for Vericel Corporation (VCEL) stock is US$28.95.
Vericel Corporation (VCEL) does not currently pay a dividend.
Stay on top of VCEL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
